events
Meet our team at the 20th Annual Meeting of the Oligonucleotide Therapeutics Society in October 6-9 for expert consultation on your drug discovery projects. Shoot an email to arrange an in-person meeting.
Read More

Nucleosides

  1. Home
  2. Products & Services
  3. Products
  4. RNA Synthesis Reagents
  5. Nucleosides
2'-Modified Nucleosides
(290/290) 3'-Modified Nucleosides
(157/157) 5'-Modified Nucleosides
(237/237) Anhydro-Nucleosides
(13/13) Arabinonucleosides
(34/34) Base Protected Nucleosides
(224/224) Halogen Nucleosides
(135/135) L-Nucleosides
(18/18) Other Nucleosides
(77/77) Other Protected Nucleosides
(23/23) Ribonucleosides
(11/11)
Backbone
Modification
Base Type
Filtered by
Clear All

5-O-DMT-N2-Dimethylformamide-2-O-methylguanosine

Description: 5-O-DMT-N2-Dimethylformamide-2-O-methylguanosine is a modified nucleoside compound commonly used in RNA synthesis and modification studies. It is often employed as a building block for the synthesis of RNA molecules with specific modifications for various biological and research purposes.
CAT: BRP-00797
CAS: 1858223-91-2
MF: C35H38N6O7
MF: 654.71
Purity: 97%
Appearance: White powder
Size Price Stock Quantity
-- -- --
Inquiry   
Storage: Store at 2-8 °C, Keep in a dark and dry place
Density: 1.33±0.1 g/cm3
Boiling Point: 848.7±75.0 °C at 760 mmHg
InChIKey: SBJHBQZDABMKCF-JHZZHVAFSA-N
CanonicalSMILES: CN(C)C=NC1=NC2=C(C(=O)N1)N=CN2C3C(C(C(O3)COC(C4=CC=CC=C4)(C5=CC=C(C=C5)OC)C6=CC=C(C=C6)OC)O)OC
IUPAC Name: N'-[9-[(2R,3R,4R,5R)-5-[[bis(4-methoxyphenyl)-phenylmethoxy]methyl]-4-hydroxy-3-methoxyoxolan-2-yl]-6-oxo-1H-purin-2-yl]-N,N-dimethylmethanimidamide
InChI: InChI=1S/C35H38N6O7/c1-40(2)20-37-34-38-31-28(32(43)39-34)36-21-41(31)33-30(46-5)29(42)27(48-33)19-47-35(22-9-7-6-8-10-22,23-11-15-25(44-3)16-12-23)24-13-17-26(45-4)18-14-24/h6-18,20-21,27,29-30,33,42H,19H2,1-5H3,(H,38,39,43)/t27-,29-,30-,33-/m1/s1
Synonyms: N'-(9-((2R,3R,4R,5R)-5-((Bis(4-methoxyphenyl)(phenyl)methoxy)methyl)-4-hydroxy-3-methoxytetrahydrofuran-2-yl)-6-oxo-6,9-dihydro-1H-purin-2-yl)-N,N-dimethylformimidamide; 5'-O-DMT-N2-DMF-2'-O-methylguanosine; N2-dmf-DMT-2'-OMe-Gr; N2-dimethylformamidine-5'-O-(4,4'-dimethoxytrityl)-2'-O-methyl-Guanosine

(E)-N2-Dimethylformamide-2-O-methylguanosine

Description: (E)-N2-Dimethylformamide-2-O-methylguanosine is a modified nucleoside compound used in RNA synthesis and modification studies. It is commonly employed as a building block for the synthesis of RNA molecules with specific modifications, allowing researchers to investigate RNA structure, function, and interactions.
CAT: BRP-00798
CAS: 1951424-87-5
MF: C14H20N6O5
MF: 352.35
Purity: 98%
Size Price Stock Quantity
-- -- --
Inquiry   
Density: 1.63±0.1 g/cm3
Boiling Point: 672.2±65.0 °C at 760 mmHg
InChIKey: KDQQTCFKBCWYFL-GTACIXLRSA-N
CanonicalSMILES: CN(C)C=NC1=NC2=C(C(=O)N1)N=CN2C3C(C(C(O3)CO)O)OC
IUPAC Name: (E)-N'-[9-[(2R,3R,4R,5R)-4-hydroxy-5-(hydroxymethyl)-3-methoxyoxolan-2-yl]-6-oxo-1H-purin-2-yl]-N,N-dimethylmethanimidamide
InChI: InChI=1S/C14H20N6O5/c1-19(2)5-16-14-17-11-8(12(23)18-14)15-6-20(11)13-10(24-3)9(22)7(4-21)25-13/h5-7,9-10,13,21-22H,4H2,1-3H3,(H,17,18,23)/b16-5+/t7-,9-,10-,13-/m1/s1
Synonyms: (E)-N-[(Dimethylamino)methylene]-2'-O-methylguanosine; (E)-N'-(9-((2R,3R,4R,5R)-4-Hydroxy-5-(hydroxymethyl)-3-methoxytetrahydrofuran-2-yl)-6-oxo-6,9-dihydro-1H-purin-2-yl)-N,N-dimethylformimidamide
Related CAS: 183737-04-4 (N-[(Dimethylamino)methylene]-2'-O-methylguanosine)

[N(E)]-N-[(Dimethylamino)methylene]guanosine

Description: [N(E)]-N-[(Dimethylamino)methylene]guanosine is a modified nucleoside compound commonly utilized in biochemical research, particularly in RNA studies. This modification is often used to investigate RNA structure, function, and interactions, providing valuable insights into biological processes such as RNA folding, RNA-protein interactions, and RNA catalysis.
CAT: BRP-00799
CAS: 1055407-32-3
MF: C13H18N6O5
MF: 338.32
Purity: 98%
Size Price Stock Quantity
-- -- --
Inquiry   
Density: 1.77±0.1 g/cm3
Boiling Point: 708.5±70.0 °C at 760 mmHg
InChIKey: WDAVDBAMSKZBEN-PZYHSTABSA-N
CanonicalSMILES: CN(C)C=NC1=NC2=C(C(=O)N1)N=CN2C3C(C(C(O3)CO)O)O
IUPAC Name: (E)-N'-[9-[(2R,3R,4S,5R)-3,4-dihydroxy-5-(hydroxymethyl)oxolan-2-yl]-6-oxo-1H-purin-2-yl]-N,N-dimethylmethanimidamide
InChI: InChI=1S/C13H18N6O5/c1-18(2)4-15-13-16-10-7(11(23)17-13)14-5-19(10)12-9(22)8(21)6(3-20)24-12/h4-6,8-9,12,20-22H,3H2,1-2H3,(H,16,17,23)/b15-4+/t6-,8-,9-,12-/m1/s1
Synonyms: (E)-N'-(9-((2R,3R,4S,5R)-3,4-Dihydroxy-5-(hydroxymethyl)tetrahydrofuran-2-yl)-6-oxo-6,9-dihydro-3H-purin-2-yl)-N,N-dimethylformimidamide; Guanosine, N-[(dimethylamino)methylene]-, [N(E)]-; (E)-N2-DMF-rG; N-dimethylaminomethylene guanosine
Related CAS: 17331-16-7 (N-[(Dimethylamino)methylene]guanosine)

2'-O-TBDMS-N2-DMF-rG

Description: 2'-O-TBDMS-N2-DMF-rG is a modified nucleoside commonly employed in RNA synthesis and modification studies. It contains a guanosine base with modifications at the 2'-position (TBDMS) and N2 position (DMF). The TBDMS group protects the 2'-hydroxyl group, while the DMF group is attached to the N2 position. This modification allows researchers to introduce specific functionalities into RNA molecules for various research purposes, such as structural studies, RNA-protein interactions, or RNA labeling experiments, providing valuable insights into RNA biology and function.
CAT: BRP-00800
CAS: 126922-63-2
MF: C19H32N6O5Si
MF: 452.58
Purity: 98%
Size Price Stock Quantity
-- -- --
Inquiry   
Density: 1.34±0.1 g/cm3
InChIKey: ILIKLOCTYDXXNJ-LSCFUAHRSA-N
CanonicalSMILES: CC(C)(C)[Si](C)(C)OC1C(C(OC1N2C=NC3=C2N=C(NC3=O)N=CN(C)C)CO)O
IUPAC Name: N'-[9-[(2R,3R,4R,5R)-3-[tert-butyl(dimethyl)silyl]oxy-4-hydroxy-5-(hydroxymethyl)oxolan-2-yl]-6-oxo-1H-purin-2-yl]-N,N-dimethylmethanimidamide
InChI: InChI=1S/C19H32N6O5Si/c1-19(2,3)31(6,7)30-14-13(27)11(8-26)29-17(14)25-10-20-12-15(25)22-18(23-16(12)28)21-9-24(4)5/h9-11,13-14,17,26-27H,8H2,1-7H3,(H,22,23,28)/t11-,13-,14-,17-/m1/s1
Synonyms: Guanosine, N-[(dimethylamino)methylene]-2'-O-[(1,1-dimethylethyl)dimethylsilyl]-; N-[(Dimethylamino)methylene]-2'-O-[(1,1-dimethylethyl)dimethylsilyl]guanosine; N'-(9-((2R,3R,4R,5R)-3-((tert-Butyldimethylsilyl)oxy)-4-hydroxy-5-(hydroxymethyl)tetrahydrofuran-2-yl)-6-oxo-6,9-dihydro-1H-purin-2-yl)-N,N-dimethylformimidamide

5-Bromotubercidin

Description: 5-Bromotubercidin is a chemical compound commonly utilized in biochemical research and drug development. It belongs to the class of tubercidin analogs and is known for its inhibitory effects on various enzymes, including kinases.
CAT: BRP-00801
CAS: 21193-80-6
MF: C11H13BrN4O4
MF: 345.15
Purity: 97%
Appearance: White to off-white solid
Size Price Stock Quantity
-- -- --
Inquiry   
Storage: Store at 2-8 °C, protect from light
Density: 2.26±0.1 g/cm3
Melting Point: 232 °C
Boiling Point: 686.9±55.0 °C at 760 mmHg
InChIKey: ZWTPRQXZXQEKFT-IOSLPCCCSA-N
Solubility: Soluble in DMSO (Slightly), Methanol (Slightly)
CanonicalSMILES: C1=C(C2=C(N=CN=C2N1C3C(C(C(O3)CO)O)O)N)Br
IUPAC Name: (2R,3R,4S,5R)-2-(4-amino-5-bromopyrrolo[2,3-d]pyrimidin-7-yl)-5-(hydroxymethyl)oxolane-3,4-diol
InChI: InChI=1S/C11H13BrN4O4/c12-4-1-16(10-6(4)9(13)14-3-15-10)11-8(19)7(18)5(2-17)20-11/h1,3,5,7-8,11,17-19H,2H2,(H2,13,14,15)/t5-,7-,8-,11-/m1/s1
Synonyms: (2R,3R,4S,5R)-2-(4-Amino-5-bromo-7H-pyrrolo[2,3-d]pyrimidin-7-yl)-5-(hydroxymethyl)tetrahydrofuran-3,4-diol; Bromotubercidin; 5-Bromo-7-β-D-ribofuranosyl-7H-pyrrolo[2,3-d]pyrimidin-4-amine; NSC103802

O2',O3',O5'-Tribenzoyl-5-methyl-2-thiouridine

Description: O2',O3',O5'-Tribenzoyl-5-methyl-2-thiouridine is a modified nucleoside compound often used in RNA research and modification studies. It contains a uridine base with modifications at the 2nd position (thio), and the 2', 3', and 5' hydroxyl groups are tribenzoylated. This modification is utilized to study RNA structure, function, and interactions, providing insights into RNA biology and potential therapeutic applications.
CAT: BRP-00802
CAS: 75921-08-3
MF: C31H26N2O8S
MF: 586.61
Purity: 98%
Size Price Stock Quantity
-- -- --
Inquiry   
Density: 1.43±0.1 g/cm3
InChIKey: JEAZFXFXZLAZLW-DLGLWYJGSA-N
CanonicalSMILES: CC1=CN(C(=S)NC1=O)C2C(C(C(O2)COC(=O)C3=CC=CC=C3)OC(=O)C4=CC=CC=C4)OC(=O)C5=CC=CC=C5
IUPAC Name: [(2R,3R,4R,5R)-3,4-dibenzoyloxy-5-(5-methyl-4-oxo-2-sulfanylidenepyrimidin-1-yl)oxolan-2-yl]methyl benzoate
InChI: InChI=1S/C31H26N2O8S/c1-19-17-33(31(42)32-26(19)34)27-25(41-30(37)22-15-9-4-10-16-22)24(40-29(36)21-13-7-3-8-14-21)23(39-27)18-38-28(35)20-11-5-2-6-12-20/h2-17,23-25,27H,18H2,1H3,(H,32,34,42)/t23-,24-,25-,27-/m1/s1
Synonyms: (2R,3R,4R,5R)-2-((Benzoyloxy)methyl)-5-(5-methyl-4-oxo-2-thioxo-3,4-dihydropyrimidin-1(2H)-yl)tetrahydrofuran-3,4-diyl dibenzoate; Uridine, 5-methyl-2-thio-, 2',3',5'-tribenzoate

2',3'-O-Isopropylidenecytidine sulfate

Description: 2',3'-O-Isopropylidenecytidine sulfate is a modified nucleoside compound frequently employed in RNA synthesis and modification studies. It contains a cytidine base with protection at the 2' and 3' hydroxyl groups by isopropylidene and is in the form of a sulfate salt.
CAT: BRP-00803
CAS: 1955522-00-5
MF: C12H19N3O9S
MF: 381.36
Purity: 98%
Size Price Stock Quantity
-- -- --
Inquiry   
InChIKey: WEIXBFRDOMNWIS-RQDZQORCSA-N
CanonicalSMILES: CC1(OC2C(OC(C2O1)N3C=CC(=NC3=O)N)CO)C.OS(=O)(=O)O
IUPAC Name: 1-[(3aR,4R,6R,6aR)-6-(hydroxymethyl)-2,2-dimethyl-3a,4,6,6a-tetrahydrofuro[3,4-d][1,3]dioxol-4-yl]-4-aminopyrimidin-2-one;sulfuric acid
InChI: InChI=1S/C12H17N3O5.H2O4S/c1-12(2)19-8-6(5-16)18-10(9(8)20-12)15-4-3-7(13)14-11(15)17;1-5(2,3)4/h3-4,6,8-10,16H,5H2,1-2H3,(H2,13,14,17);(H2,1,2,3,4)/t6-,8-,9-,10-;/m1./s1
Synonyms: 4-Amino-1-((3aR,4R,6R,6aR)-6-(hydroxymethyl)-2,2-dimethyltetrahydrofuro[3,4-d][1,3]dioxol-4-yl)pyrimidin-2(1H)-one sulfate; 2',3'-Isopropylidenecytidine sulfate; 2',3'-O-(1-Methylethylidene)cytidine sulfate
Related CAS: 362-42-5 (free base)

1-(β-D-lyxofuranosyl)uracil

Description: 1-(β-D-lyxofuranosyl)uracil is a nucleoside compound commonly used in nucleic acid research and drug development. This modified nucleoside is employed in the study of nucleic acid structure and function, and can be used as an analog in the synthesis of oligonucleotides. Additionally, it has potential applications in the development of antiviral and anticancer therapeutics by mimicking natural nucleosides and interfering with nucleic acid metabolism.
CAT: BRP-00804
CAS: 4348-61-2
MF: C9H12N2O6
MF: 244.20
Purity: 98%
Size Price Stock Quantity
-- -- --
Inquiry   
Density: 1.674±0.06 g/cm3 (Predicted)
Melting Point: 203-204 °C
InChIKey: DRTQHJPVMGBUCF-YDKYIBAVSA-N
CanonicalSMILES: C1=CN(C(=O)NC1=O)C2C(C(C(O2)CO)O)O
IUPAC Name: 1-[(2R,3S,4R,5R)-3,4-dihydroxy-5-(hydroxymethyl)oxolan-2-yl]pyrimidine-2,4-dione
InChI: InChI=1S/C9H12N2O6/c12-3-4-6(14)7(15)8(17-4)11-2-1-5(13)10-9(11)16/h1-2,4,6-8,12,14-15H,3H2,(H,10,13,16)/t4-,6+,7+,8-/m1/s1
Synonyms: 1-((2R,3S,4R,5R)-3,4-dihydroxy-5-(hydroxymethyl)tetrahydrofuran-2-yl)pyrimidine-2,4(1H,3H)-dione; 1-β-D-lyxofuranosyl-uracil; 2,4(1H,3H)-Pyrimidinedione, 1-β-D-lyxofuranosyl-

(E)-Ethyl 3-(1-((2R,3R,4S,5R)-3,4-dihydroxy-5-(hydroxymethyl)tetrahydrofuran-2-yl)-2,4-dioxo-1,2,3,4-tetrahydropyrimidin-5-yl)acrylate

Description: (E)-Ethyl 3-(1-((2R,3R,4S,5R)-3,4-dihydroxy-5-(hydroxymethyl)tetrahydrofuran-2-yl)-2,4-dioxo-1,2,3,4-tetrahydropyrimidin-5-yl)acrylate is a modified nucleoside derivative used in biochemical and pharmaceutical research. The modifications enhance its utility in studying nucleic acid interactions and functions, and it can serve as an intermediate in the synthesis of nucleoside analogs. These analogs have potential therapeutic applications, particularly in antiviral and anticancer treatments, by interfering with nucleic acid metabolism and replication processes.
CAT: BRP-00805
CAS: 123881-85-6
MF: C14H18N2O8
MF: 342.30
Purity: 98%
Size Price Stock Quantity
-- -- --
Inquiry   
Storage: Store at 2-8 °C
Density: 1.583±0.06 g/cm3
InChIKey: ATSFSUUXRHMGQU-BGFIHSBQSA-N
CanonicalSMILES: CCOC(=O)C=CC1=CN(C(=O)NC1=O)C2C(C(C(O2)CO)O)O
IUPAC Name: ethyl (E)-3-[1-[(2R,3R,4S,5R)-3,4-dihydroxy-5-(hydroxymethyl)oxolan-2-yl]-2,4-dioxopyrimidin-5-yl]prop-2-enoate
InChI: InChI=1S/C14H18N2O8/c1-2-23-9(18)4-3-7-5-16(14(22)15-12(7)21)13-11(20)10(19)8(6-17)24-13/h3-5,8,10-11,13,17,19-20H,2,6H2,1H3,(H,15,21,22)/b4-3+/t8-,10-,11-,13-/m1/s1
Synonyms: 2-Propenoic acid, 3-[1,2,3,4-tetrahydro-2,4-dioxo-1-β-D-ribofuranosyl-5-pyrimidinyl]-, ethyl ester, (E)-

6-Fluoro-3,4-dihydro-3-oxo-4-(2,3,5-tri-O-acetyl-β-D-ribofuranosyl)pyrazinecarboxamide

Description: 6-Fluoro-3,4-dihydro-3-oxo-4-(2,3,5-tri-O-acetyl-β-D-ribofuranosyl)pyrazinecarboxamide is a modified nucleoside analog used in biochemical research and pharmaceutical development. The modifications enhance its stability and facilitate its incorporation into nucleic acids. It is often utilized in the synthesis of nucleoside analogs for studying nucleic acid interactions, function, and potential therapeutic applications, particularly in the development of antiviral and anticancer agents.
CAT: BRP-00807
CAS: 499785-96-5
MF: C16H18FN3O9
MF: 415.33
Purity: 98%
Size Price Stock Quantity
-- -- --
Inquiry   
Density: 1.61±0.1 g/cm3
Boiling Point: 524.4±60.0 °C at 760 mmHg
InChIKey: IVDSFFUXGZDUGN-RVXWVPLUSA-N
CanonicalSMILES: CC(=O)OCC1C(C(C(O1)N2C=C(N=C(C2=O)C(=O)N)F)OC(=O)C)OC(=O)C
IUPAC Name: [(2R,3R,4R,5R)-3,4-diacetyloxy-5-(3-carbamoyl-5-fluoro-2-oxopyrazin-1-yl)oxolan-2-yl]methyl acetate
InChI: InChI=1S/C16H18FN3O9/c1-6(21)26-5-9-12(27-7(2)22)13(28-8(3)23)16(29-9)20-4-10(17)19-11(14(18)24)15(20)25/h4,9,12-13,16H,5H2,1-3H3,(H2,18,24)/t9-,12-,13-,16-/m1/s1
Synonyms: Pyrazinecarboxamide, 6-fluoro-3,4-dihydro-3-oxo-4-(2,3,5-tri-O-acetyl-β-D-ribofuranosyl)-; Acetic acid (2R,3R,4R,5R)-3,4-diacetoxy-5-(3-carbamoyl-5-fluoro-2-oxo-2H-pyrazin-1-yl)-tetrahydro-furan-2-ylmethyl ester; (2R,3R,4R,5R)-2-(Acetoxymethyl)-5-(3-carbamoyl-5-fluoro-2-oxopyrazin-1(2H)-yl)tetrahydrofuran-3,4-diyl diacetate

2-O-Ethyl-2'-O-methyluridine

Description: 2-O-Ethyl-2'-O-methyluridine is a modified nucleoside used in biochemical research, particularly in the study of RNA synthesis and modification. These modifications increase the stability and resistance to enzymatic degradation of the nucleoside, making it useful in the development of therapeutic oligonucleotides and the study of RNA structure and function.
CAT: BRP-00808
CAS: 1352173-49-9
MF: C12H18N2O6
MF: 286.28
Purity: 98%
Size Price Stock Quantity
-- -- --
Inquiry   
Density: 1.47±0.1 g/cm3
Boiling Point: 466.2±55.0 °C at 760 mmHg
InChIKey: NZNRDRCBHUXJKX-QCNRFFRDSA-N
CanonicalSMILES: CCOC1=NC(=O)C=CN1C2C(C(C(O2)CO)O)OC
IUPAC Name: 2-ethoxy-1-[(2R,3R,4R,5R)-4-hydroxy-5-(hydroxymethyl)-3-methoxyoxolan-2-yl]pyrimidin-4-one
InChI: InChI=1S/C12H18N2O6/c1-3-19-12-13-8(16)4-5-14(12)11-10(18-2)9(17)7(6-15)20-11/h4-5,7,9-11,15,17H,3,6H2,1-2H3/t7-,9-,10-,11-/m1/s1
Synonyms: 2'-O-Methyl-2-O-ethyluridine; 2-Ethoxy-1-((2R,3R,4R,5R)-4-hydroxy-5-(hydroxymethyl)-3-methoxytetrahydrofuran-2-yl)pyrimidin-4(1H)-one

S-(5')-Adenosyl-3-thiopropylamine

Description: S-(5')-Adenosyl-3-thiopropylamine is a modified nucleoside compound used in biochemical research, particularly in the study of enzyme mechanisms and metabolic pathways. This compound consists of an adenosine moiety linked to a 3-thiopropylamine group via a sulfur atom at the 5' position. It serves as a cofactor or substrate analog in various enzymatic reactions, providing insights into the role of sulfur-containing nucleosides in biological processes and potential therapeutic applications.
CAT: BRP-00810
CAS: 53186-57-5
MF: C13H20N6O3S
MF: 340.40
Purity: 98%
Size Price Stock Quantity
-- -- --
Inquiry   
Density: 1.78±0.1 g/cm3
Boiling Point: 683.7±65.0 °C at 760 mmHg
InChIKey: FUSRAALGPJJIRO-QYVSTXNMSA-N
CanonicalSMILES: C1=NC(=C2C(=N1)N(C=N2)C3C(C(C(O3)CSCCCN)O)O)N
IUPAC Name: (2S,3S,4R,5R)-2-(3-aminopropylsulfanylmethyl)-5-(6-aminopurin-9-yl)oxolane-3,4-diol
InChI: InChI=1S/C13H20N6O3S/c14-2-1-3-23-4-7-9(20)10(21)13(22-7)19-6-18-8-11(15)16-5-17-12(8)19/h5-7,9-10,13,20-21H,1-4,14H2,(H2,15,16,17)/t7-,9-,10-,13-/m1/s1
Synonyms: S-Adenosyl-3-thiopropylamine; 5'-S-(3-Aminopropyl)-5'-thioadenosine; 5''-(Aminopropylthio)-5''-deoxy-adenosine; (2R,3R,4S,5S)-2-(6-amino-9H-purin-9-yl)-5-((3-aminopropylthio)methyl)tetrahydrofuran-3,4-diol
Related CAS: 99019-00-8 (sulfate)

N4-Ac-2'-O-4'-C-Locked-Cr

Description: N4-Ac-2'-O-4'-C-Locked-Cr is a modified nucleoside used in oligonucleotide synthesis. It consists of an acetyl group (Ac) at the N4 position of the cytosine, a 2'-O modification, and a 4'-carbon locked cytosine (Locked-Cr). This modification is designed to stabilize the oligonucleotide structure and alter its properties for specific applications in nucleic acid research and biotechnology.
CAT: BRP-00986
CAS: 391199-75-0
MF: C12H15N3O6
MF: 297.27
Size Price Stock Quantity
-- -- --
Inquiry   
Density: 1.77±0.1 g/cm3
Melting Point: 223-225 °C (dec.)
InChIKey: DLDUBZSJKKUTMP-KLBPJQLPSA-N
CanonicalSMILES: CC(=O)NC1=NC(=O)N(C=C1)C2C3C(C(O2)(CO3)CO)O
IUPAC Name: N-[1-[(1S,3R,4R,7S)-7-hydroxy-1-(hydroxymethyl)-2,5-dioxabicyclo[2.2.1]heptan-3-yl]-2-oxopyrimidin-4-yl]acetamide
InChI: InChI=1S/C12H15N3O6/c1-6(17)13-7-2-3-15(11(19)14-7)10-8-9(18)12(4-16,21-10)5-20-8/h2-3,8-10,16,18H,4-5H2,1H3,(H,13,14,17,19)/t8-,9+,10-,12+/m1/s1
Synonyms: N4-acetyl-2'-O-4'-C-Locked-cytidine; Acetamide, N-[1-[2,5-anhydro-4-C-(hydroxymethyl)-α-L-lyxofuranosyl]-1,2-dihydro-2-oxo-4-pyrimidinyl]-; LNA C(Ac)

N4-Dibutylformamidine-2'-O-Me-Cr

Description: N4-Dibutylformamidine-2'-O-Me-Cr is a modified nucleoside used in oligonucleotide synthesis. It consists of a dibutylformamidine group attached to the N4 position of cytosine, a methyl (Me) group at the 2' position of ribose, and a modified cytosine (Cr). This modification alters the properties of the oligonucleotide and can be utilized for specific applications in nucleic acid research and biotechnology.
CAT: BRP-00987
MF: C19H32N4O5
MF: 396.49
Purity: ≥98% by HPLC
Appearance: White powder
Size Price Stock Quantity
-- -- --
Inquiry   
Storage: Store at 2-8 °C, Keep in a dark and dry place
InChIKey: MMQXUCDIZCUQOH-VDHUWJSZSA-N
IUPAC Name: N,N-dibutyl-N'-(1-((2R,3R,4R,5R)-4-hydroxy-5-(hydroxymethyl)-3-methoxytetrahydrofuran-2-yl)-2-oxo-1,2-dihydropyrimidin-4-yl)formimidamide
InChI: InChI=1S/C19H32N4O5/c1-4-6-9-22(10-7-5-2)13-20-15-8-11-23(19(26)21-15)18-17(27-3)16(25)14(12-24)28-18/h8,11,13-14,16-18,24-25H,4-7,9-10,12H2,1-3H3/t14-,16-,17-,18-/m1/s1
Synonyms: N4-dibutylformamidine-2'-O-methyl-cytidine

N1-Methylene pivalate-N2-dibutylformamidine-2'-O-Me-Gr

Description: N1-Methylene pivalate-N2-dibutylformamidine-2'-O-Me-Gr is a modified nucleoside used in oligonucleotide synthesis. It consists of a methylene pivalate group attached to the N1 position of guanine, a dibutylformamidine group attached to the N2 position of guanine, a methyl (Me) group at the 2' position of ribose, and a modified guanine (Gr). This modification alters the properties of the oligonucleotide and can be employed for specific applications in nucleic acid research and biotechnology.
CAT: BRP-00988
MF: C26H42N6O7
MF: 550.66
Purity: ≥98% by HPLC
Appearance: White powder
Size Price Stock Quantity
-- -- --
Inquiry   
Storage: Store at 2-8 °C, Keep in a dark and dry place
InChIKey: FJYUEQOQXMHZLF-ZDXOVATRSA-N
IUPAC Name: (2-(((dibutylamino)methylene)amino)-9-((2R,3R,4R,5R)-4-hydroxy-5-(hydroxymethyl)-3-methoxytetrahydrofuran-2-yl)-6-oxo-6,9-dihydro-1H-purin-1-yl)methyl pivalate
InChI: InChI=1S/C26H42N6O7/c1-7-9-11-30(12-10-8-2)14-28-25-29-21-18(22(35)32(25)16-38-24(36)26(3,4)5)27-15-31(21)23-20(37-6)19(34)17(13-33)39-23/h14-15,17,19-20,23,33-34H,7-13,16H2,1-6H3/t17-,19-,20-,23-/m1/s1
Synonyms: N1-methylene pivalate-N2-dibutylformamidine-2'-O-methyl-guanosine

N2-Dibutylformamidine-2'-O-Me-Gr

Description: N2-Dibutylformamidine-2'-O-Me-Gr is a modified nucleoside used in oligonucleotide synthesis. It consists of a dibutylformamidine group attached to the N2 position of guanine, a methyl (Me) group at the 2' position of ribose, and a modified guanine (Gr). This modification can alter the properties of the oligonucleotide for specific applications in nucleic acid research and biotechnology.
CAT: BRP-00989
MF: C20H32N6O5
MF: 436.51
Purity: ≥98% by HPLC
Appearance: White powder
Size Price Stock Quantity
-- -- --
Inquiry   
Storage: Store at 2-8 °C, Keep in a dark and dry place
InChIKey: KZJIRTOCSLCQKS-NVQRDWNXSA-N
IUPAC Name: N,N-dibutyl-N'-(9-((2R,3R,4R,5R)-4-hydroxy-5-(hydroxymethyl)-3-methoxytetrahydrofuran-2-yl)-6-oxo-6,9-dihydro-1H-purin-2-yl)formimidamide
InChI: InChI=1S/C20H32N6O5/c1-4-6-8-25(9-7-5-2)11-22-20-23-17-14(18(29)24-20)21-12-26(17)19-16(30-3)15(28)13(10-27)31-19/h11-13,15-16,19,27-28H,4-10H2,1-3H3,(H,23,24,29)/t13-,15-,16-,19-/m1/s1
Synonyms: N2-dibutylformamidine-2'-O-methyl-guanosine

8-Br-N2-iBu-2'-OMe-Gr

Description: 8-Br-N2-iBu-2'-OMe-Gr is a modified nucleoside used in oligonucleotide synthesis. It consists of a bromine (Br) atom at the 8th position of guanine, an isobutyl (iBu) group attached to the N2 position of guanine, a methyl (Me) group at the 2' position of ribose, and a modified guanine (Gr). This modification can introduce specific properties or functionalities to the oligonucleotide for various applications in nucleic acid research and biotechnology.
CAT: BRP-00990
CAS: 2920231-98-5
MF: C15H20BrN5O6
MF: 446.25
Size Price Stock Quantity
-- -- --
Inquiry   
Density: 1.93±0.1 g/cm3
InChIKey: VMDRFWCYFGNAGO-HTVVRFAVSA-N
CanonicalSMILES: CC(C)C(=O)NC1=NC2=C(C(=O)N1)N=C(N2C3C(C(C(O3)CO)O)OC)Br
IUPAC Name: N-[8-bromo-9-[(2R,3R,4R,5R)-4-hydroxy-5-(hydroxymethyl)-3-methoxyoxolan-2-yl]-6-oxo-1H-purin-2-yl]-2-methylpropanamide
InChI: InChI=1S/C15H20BrN5O6/c1-5(2)11(24)19-15-18-10-7(12(25)20-15)17-14(16)21(10)13-9(26-3)8(23)6(4-22)27-13/h5-6,8-9,13,22-23H,4H2,1-3H3,(H2,18,19,20,24,25)/t6-,8-,9-,13-/m1/s1
Synonyms: 8-bromo-N2-isobutyryl-2'-O-methyl-guanosine; N2-Isobutyryl-8-bromo-2'-O-methyl-guanosine; N-(8-bromo-9-((2R,3R,4R,5R)-4-hydroxy-5-(hydroxymethyl)-3-methoxytetrahydrofuran-2-yl)-6-oxo-6,9-dihydro-1H-purin-2-yl)isobutyramide; N2-iBu-8-Br-2'-O-Me-G

N4-Ac-5-I-2'-O-Me-Cr

Description: N4-Ac-5-I-2'-O-Me-Cr is a modified nucleoside used in oligonucleotide synthesis. It consists of an acetyl group (Ac) at the N4 position of cytosine, an iodine atom (I) at the 5th position of cytosine, a methyl (Me) group at the 2' position of ribose, and a modified cytosine (Cr). This modification can impart specific properties or functionalities to the oligonucleotide for various applications in nucleic acid research and biotechnology.
CAT: BRP-00991
CAS: 1402062-84-3
MF: C12H16IN3O6
MF: 425.18
Size Price Stock Quantity
-- -- --
Inquiry   
Density: 2.05±0.1 g/cm3
InChIKey: UKLQCCOIWJBTQA-TURQNECASA-N
CanonicalSMILES: CC(=O)NC1=NC(=O)N(C=C1I)C2C(C(C(O2)CO)O)OC
IUPAC Name: N-[1-[(2R,3R,4R,5R)-4-hydroxy-5-(hydroxymethyl)-3-methoxyoxolan-2-yl]-5-iodo-2-oxopyrimidin-4-yl]acetamide
InChI: InChI=1S/C12H16IN3O6/c1-5(18)14-10-6(13)3-16(12(20)15-10)11-9(21-2)8(19)7(4-17)22-11/h3,7-9,11,17,19H,4H2,1-2H3,(H,14,15,18,20)/t7-,8-,9-,11-/m1/s1
Synonyms: N4-Acetyl-5-iodo-2'-O-methyl-cytidine; N-Acetyl-5-iodo-2'-O-methylcytidine; N-(1-((2R,3R,4R,5R)-4-hydroxy-5-(hydroxymethyl)-3-methoxytetrahydrofuran-2-yl)-5-iodo-2-oxo-1,2-dihydropyrimidin-4-yl)acetamide

DiPac-2,6-diamino-2'-OMe-purine-ribose

Description: DiPac-2,6-diamino-2'-OMe-purine-ribose is a modified nucleoside used in oligonucleotide synthesis. This modification consists of a DiPac (diphenoxyacetyl) group attached to the 2-amino and 6-amino positions of purine, and a methyl (Me) group at the 2' position of ribose. It is utilized in oligonucleotide synthesis to introduce specific functionalities or properties into the oligonucleotide sequence.
CAT: BRP-00992
MF: C27H30N6O8
MF: 566.56
Size Price Stock Quantity
-- -- --
Inquiry   
InChIKey: PVYFBCVGORXSLW-CCCLMZFYSA-N
IUPAC Name: N,N'-(9-((2R,3R,4R,5R)-4-hydroxy-5-(hydroxymethyl)-3-methoxytetrahydrofuran-2-yl)-6,9-dihydro-1H-purine-2,6-diyl)bis(2-phenoxyacetamide)
InChI: InChI=1S/C27H30N6O8/c1-38-23-22(37)18(12-34)41-26(23)33-15-28-21-24(29-19(35)13-39-16-8-4-2-5-9-16)31-27(32-25(21)33)30-20(36)14-40-17-10-6-3-7-11-17/h2-11,15,18,22-24,26,34,37H,12-14H2,1H3,(H,29,35)(H2,30,31,32,36)/t18-,22-,23-,24?,26-/m1/s1
Synonyms: DiPac-2,6-diamino-2'-O-methyl-purine-ribose; N2-amino-Pac-2'-O-Me-A(N6-Pac)

N6-iBu-2'-OMe-Ar

Description: N6-iBu-2'-OMe-Ar includes an isobutyl (iBu) group attached to the N6 position of adenine, a methyl (Me) group at the 2' position of ribose, and an aromatic group (Ar). It is utilized in oligonucleotide synthesis and can introduce specific functionalities to the oligonucleotide.
CAT: BRP-00993
CAS: 1084891-36-0
MF: C15H21N5O5
MF: 351.36
Size Price Stock Quantity
-- -- --
Inquiry   
Density: 1.59±0.1 g/cm3
InChIKey: IRXHRDQDJTWQAV-ORXWAGORSA-N
CanonicalSMILES: CC(C)C(=O)NC1=C2C(=NC=N1)N(C=N2)C3C(C(C(O3)CO)O)OC
IUPAC Name: N-[9-[(2R,3R,4R,5R)-4-hydroxy-5-(hydroxymethyl)-3-methoxyoxolan-2-yl]purin-6-yl]-2-methylpropanamide
InChI: InChI=1S/C15H21N5O5/c1-7(2)14(23)19-12-9-13(17-5-16-12)20(6-18-9)15-11(24-3)10(22)8(4-21)25-15/h5-8,10-11,15,21-22H,4H2,1-3H3,(H,16,17,19,23)/t8-,10-,11-,15-/m1/s1
Synonyms: N6-isobutyryl-2'-O-methyl-adenosine; N-(9-((2R,3R,4R,5R)-4-hydroxy-5-(hydroxymethyl)-3-methoxytetrahydrofuran-2-yl)-9H-purin-6-yl)isobutyramide; 2'-O-Methyl-N-(2-methyl-1-oxopropyl)adenosine
* Only for research. Not suitable for any diagnostic or therapeutic use.

logo

Global Supplier of High-Quality RNA / DNA Products & Services.

        Ordering
Copyright © 2024 BOC Sciences. All rights reserved.
USA
    • International:
    • US & Canada (Toll free):
  • Fax:
  • Email:
UK
  • Tel:
  • Email:
Inquiry Basket
Loading ......
Delete selectedGo to checkout